We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
When it comes to Bristol-Myers Squibb, the rumors are true. Activist investor Starboard Value has indeed taken a stake in the merger-bound pharma—and it’s looking to meddle further.